These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 18258752)

  • 1. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway.
    de la Iglesia N; Konopka G; Puram SV; Chan JA; Bachoo RM; You MJ; Levy DE; Depinho RA; Bonni A
    Genes Dev; 2008 Feb; 22(4):449-62. PubMed ID: 18258752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation.
    Puram SV; Yeung CM; Jahani-Asl A; Lin C; de la Iglesia N; Konopka G; Jackson-Grusby L; Bonni A
    J Neurosci; 2012 Jun; 32(23):7806-18. PubMed ID: 22674257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts.
    Lal B; Goodwin CR; Sang Y; Foss CA; Cornet K; Muzamil S; Pomper MG; Kim J; Laterra J
    Mol Cancer Ther; 2009 Jul; 8(7):1751-60. PubMed ID: 19584231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
    Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
    Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness.
    de la Iglesia N; Konopka G; Lim KL; Nutt CL; Bromberg JF; Frank DA; Mischel PS; Louis DN; Bonni A
    J Neurosci; 2008 Jun; 28(23):5870-8. PubMed ID: 18524891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line.
    Moon SH; Kim DK; Cha Y; Jeon I; Song J; Park KS
    Int J Oncol; 2013 Mar; 42(3):921-8. PubMed ID: 23314408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
    Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H
    Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.
    Fan QW; Cheng CK; Gustafson WC; Charron E; Zipper P; Wong RA; Chen J; Lau J; Knobbe-Thomsen C; Weller M; Jura N; Reifenberger G; Shokat KM; Weiss WA
    Cancer Cell; 2013 Oct; 24(4):438-49. PubMed ID: 24135280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis.
    Vitucci M; Karpinich NO; Bash RE; Werneke AM; Schmid RS; White KK; McNeill RS; Huff B; Wang S; Van Dyke T; Miller CR
    Neuro Oncol; 2013 Oct; 15(10):1317-29. PubMed ID: 23814263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 regulation of glioblastoma pathogenesis.
    de la Iglesia N; Puram SV; Bonni A
    Curr Mol Med; 2009 Jun; 9(5):580-90. PubMed ID: 19601808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.
    Jahani-Asl A; Yin H; Soleimani VD; Haque T; Luchman HA; Chang NC; Sincennes MC; Puram SV; Scott AM; Lorimer IA; Perkins TJ; Ligon KL; Weiss S; Rudnicki MA; Bonni A
    Nat Neurosci; 2016 Jun; 19(6):798-806. PubMed ID: 27110918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells.
    Garnett J; Chumbalkar V; Vaillant B; Gururaj AE; Hill KS; Latha K; Yao J; Priebe W; Colman H; Elferink LA; Bogler O
    Neoplasia; 2013 Jan; 15(1):73-84. PubMed ID: 23359207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer.
    Mehrian-Shai R; Chen CD; Shi T; Horvath S; Nelson SF; Reichardt JK; Sawyers CL
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5563-8. PubMed ID: 17372210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes.
    Lo HW; Cao X; Zhu H; Ali-Osman F
    Mol Cancer Res; 2010 Feb; 8(2):232-45. PubMed ID: 20145033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of the pro-inflammatory biomarker, YKL-40/CHI3L1, by PTEN/Phosphoinositide 3-kinase and JAK2/STAT3 pathways in glioblastoma.
    Wang Y; Wong CW; Yan M; Li L; Liu T; Or PM; Tsui SK; Waye MM; Chan AM
    Cancer Lett; 2018 Aug; 429():54-65. PubMed ID: 29729901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking the bFGF/STAT3 interaction through specific signaling pathways induces apoptosis in glioblastoma cells.
    Wu J; Feng X; Zhang B; Li J; Xu X; Liu J; Wang X; Wang J; Tong X
    J Neurooncol; 2014 Oct; 120(1):33-41. PubMed ID: 25048528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.
    Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM
    Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
    Hu X; Pandolfi PP; Li Y; Koutcher JA; Rosenblum M; Holland EC
    Neoplasia; 2005 Apr; 7(4):356-68. PubMed ID: 15967113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors.
    Li L; Dutra A; Pak E; Labrie JE; Gerstein RM; Pandolfi PP; Recht LD; Ross AH
    Neuro Oncol; 2009 Feb; 11(1):9-21. PubMed ID: 18812521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR and EGFRvIII in glioblastoma: partners in crime.
    Zadeh G; Bhat KP; Aldape K
    Cancer Cell; 2013 Oct; 24(4):403-4. PubMed ID: 24135276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.